A novel purified Lactobacillus acidophilus 20079 exopolysaccharide, LA-EPS-20079, molecularly regulates both apoptotic and NF-κB inflammatory pathways in human colon cancer

Abstract Background The direct link between inflammatory bowel diseases and colorectal cancer is well documented. Previous studies have reported that some lactic acid bacterial strains could inhibit colon cancer progression however; the exact molecules involved have not yet been identified. So, in the current study, we illustrated the tumor suppressive effects of the newly identified Lactobacillus acidophilus DSMZ 20079 cell-free pentasaccharide against colon cancer cells. The chemical structure of the purified pentasaccharide was investigated by MALDI-TOF mass spectrum, 1D and 2D Nuclear Magnetic Resonance (NMR). The anticancer potentiality of the purified pentasaccharide against both Human colon cancer (CaCo-2) and Human breast cancer (MCF7) cell lines with its safety usage pattern were evaluated using cytotoxicity, annexin V quantification and BrdU incorporation assays. Also, the immunomodulatory effects of the identified compound were quantified on both LPS-induced PBMC cell model and cancer cells with monitoring the immunophenotyping of T and dendritic cell surface marker. At molecular level, the alteration in gene expression of both inflammatory and apoptotic pathways were quantified upon pentasaccharide-cellular treatment by RTqPCR. Results The obtained data of the spectroscopic analysis, confirmed the structure of the newly extracted pentasaccharide; (LA-EPS-20079) to be: α-d-Glc (1→2)][α-l-Fuc(1→4)] α-d-GlcA(1→2) α-d-GlcA(1→2) α-d-GlcA. This pentasaccharide, recorded safe dose on normal mammalian cells ranged from 2 to 5 mg/ml with cancer cells selectivity index, ranged of 1.96–51.3. Upon CaCo-2 cell treatment with the non-toxic dose of LA-EPS-20079, the inhibition percentage in CaCo-2 cellular viability, reached 80.65 with an increase in the ratio of the apoptotic cells in sub-G0/G1 cell cycle phase. Also, this pentasaccharide showed potentialities to up-regulate the expression of IKbα, P53 and TGF genes. Conclusion The anticancer potentialities of LA-EPS-20079 oligosaccharides against human colon cancer represented through its regulatory effects on both apoptotic and NF-κB inflammatory pathways

Volatiles profiling and bioactivities of <i>Cupressus</i> spp. leaf and cone essential oils as analyzed via chemometrics tools

<p><i>Cupressus</i> is a genus of considerable medicinal value worldwide. The present work aims at assessing essential oil compositional differences within <i>Cupressus</i> in the context of its different genotypes and organs. Volatiles profiling was determined via gas chromatography-mass spectrometry coupled to chemometrics. A total of 75 volatile components were identified. Monoterpene hydrocarbons amounted for the major volatile class, with α-pinene and 3-carene most abundant in <i>Cupressus sempervirens</i> versus sabinene and terpinen-4-ol in <i>Cupressus macrocarpa</i>. Multivariate data analyses revealed that α-pinene, sabinene, terpinen-4-ol and 3-carene are the most significant for species classification. The five examined essential oils exhibited potential insecticidal and anticholinesterase effects, with C. <i>sempervirens</i> var. pyramidalis cone oil being the most potent for acetylcholinesterase inhibitory effect. The oil also exhibited potential fumigant toxicity toward <i>Sitophilus oryzae</i> and <i>Tribolium castaneum</i>.  The results of the orthogonal partial least-square discriminant analysis revealed that α-pinene is the key bioactive component in <i>Cupressus oil</i>.</p